This HTML5 document contains 1 embedded RDF statements represented using HTML+Microdata notation.
The embedded RDF content will be recognized by any processor of HTML5 Microdata.
| Prefix | Namespace IRI |
|---|
| rdfs | http://www.w3.org/2000/01/rdf-schema# |
| rdf | http://www.w3.org/1999/02/22-rdf-syntax-ns# |
| xsdh | http://www.w3.org/2001/XMLSchema# |
| dbpedia | http://dbpedia.org/resource/ |
- Subject Item
- dbpedia:Abraxis_BioScience
- rdfs:comment
-
Abraxis BioScience is a global biopharmaceutical company dedicated to meeting the needs of critically ill patients, with over 2000 employees worldwide. Abraxis' portfolio includes the world's first protein-based nanoparticle chemotherapeutic compound called nab Technology. From this the company has developed Abraxane, a treatment for metastatic breast cancer. On June 30, 2010, it was announced that Abraxis BioScience would be acquired by Celgene Corporation.